Engineers Gate Manager LP Organogenesis Holdings Inc. Transaction History

Engineers Gate Manager LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.9 - $4.3 $11,154 - $25,245	5,871 Added 40.54%	20,354 $67,000
Q1 2023 May 15, 2023	SELL	$1.89 - $2.93 $3,126 - $4,846	-1,654 Reduced 10.25%	14,483 $30,000
Q4 2022 Feb 14, 2023	SELL	$2.48 - $3.43 $10,331 - $14,289	-4,166 Reduced 20.52%	16,137 $43,000
Q3 2022 Nov 14, 2022	SELL	$3.14 - $6.43 $190,478 - $390,056	-60,662 Reduced 74.92%	20,303 $66,000
Q2 2022 Aug 15, 2022	BUY	$4.74 - $8.15 $237,132 - $407,728	50,028 Added 161.71%	80,965 $395,000
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $200,162 - $296,067	30,937 New	30,937 $236,000
Q4 2021 Feb 14, 2022	SELL	$9.02 - $13.5 $178,415 - $267,030	-19,780 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.71 - $17.18 $94,324 - $118,198	6,880 Added 53.33%	19,780 $282,000
Q2 2021 Aug 16, 2021	BUY	$14.92 - $23.23 $192,468 - $299,667	12,900 New	12,900 $214,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.